Literature DB >> 29129852

One-year eGFR decline rate is a good predictor of prognosis of renal failure in patients with type 2 diabetes.

Jun Nojima1, Shu Meguro1, Naoto Ohkawa2, Michiaki Furukoshi3, Toshihide Kawai4, Hiroshi Itoh1.   

Abstract

It is difficult to distinguish the onset of renal function decline from the typical variation in estimated glomerular filtration rate (eGFR) measurements in clinical practice. In this study, we used data analysis incorporating smoothing techniques to identify significant trends despite large amounts of noise. We identified the starting points of meaningful eGFR decline based on eGFR trajectories. This was a retrospective observational study of 2533 type 2 diabetes patients. We calculated 1-year eGFR decline rates from the difference between each eGFR value and that of the previous year. We examined the prediction capacity of 1-year eGFR decline rate for renal prognosis. When we performed receiver operating characteristic analysis, the area under the curve of 1-year eGFR decline rate was 0.963 (95% confidence interval: 0.953-0.973). With a cut-off value of more than 7.5% eGFR decline during a 1-year period, the sensitivity was 98.8% and specificity was 82.3%. The predictive accuracy of 1-year eGFR decline rate for renal prognosis was high.

Entities:  

Keywords:  change in eGFR; renal outcome; type 2 diabetic nephropathy

Mesh:

Year:  2017        PMID: 29129852      PMCID: PMC5743850          DOI: 10.2183/pjab.93.046

Source DB:  PubMed          Journal:  Proc Jpn Acad Ser B Phys Biol Sci        ISSN: 0386-2208            Impact factor:   3.493


  18 in total

1.  Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts.

Authors:  Ron T Gansevoort; Kunihiro Matsushita; Marije van der Velde; Brad C Astor; Mark Woodward; Andrew S Levey; Paul E de Jong; Josef Coresh
Journal:  Kidney Int       Date:  2011-02-02       Impact factor: 10.612

2.  Evaluation of acquired cystic kidney disease in patients on hemodialysis with ultrasonography.

Authors:  Seyed Seifollah Beladi Mousavi; Moshgan Sametzadeh; Fatemeh Hayati; Seyed Mahmoud Fatemi
Journal:  Iran J Kidney Dis       Date:  2010-07       Impact factor: 0.892

3.  Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.

Authors:  Kunihiro Matsushita; Marije van der Velde; Brad C Astor; Mark Woodward; Andrew S Levey; Paul E de Jong; Josef Coresh; Ron T Gansevoort
Journal:  Lancet       Date:  2010-05-17       Impact factor: 79.321

4.  Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.

Authors:  Areef Ishani; Greg A Grandits; Richard H Grimm; Kenneth H Svendsen; Allan J Collins; Ronald J Prineas; James D Neaton
Journal:  J Am Soc Nephrol       Date:  2006-04-12       Impact factor: 10.121

5.  Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.

Authors:  Peter Gaede; Pernille Vedel; Nicolai Larsen; Gunnar V H Jensen; Hans-Henrik Parving; Oluf Pedersen
Journal:  N Engl J Med       Date:  2003-01-30       Impact factor: 91.245

6.  Proteinuria and the risk of developing end-stage renal disease.

Authors:  Kunitoshi Iseki; Yoshiharu Ikemiya; Chiho Iseki; Shuichi Takishita
Journal:  Kidney Int       Date:  2003-04       Impact factor: 10.612

7.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

8.  Effect of a multifactorial intervention on mortality in type 2 diabetes.

Authors:  Peter Gaede; Henrik Lund-Andersen; Hans-Henrik Parving; Oluf Pedersen
Journal:  N Engl J Med       Date:  2008-02-07       Impact factor: 91.245

9.  Report of the committee on the classification and diagnostic criteria of diabetes mellitus.

Authors:  Yutaka Seino; Kishio Nanjo; Naoko Tajima; Takashi Kadowaki; Atsunori Kashiwagi; Eiichi Araki; Chikako Ito; Nobuya Inagaki; Yasuhiko Iwamoto; Masato Kasuga; Toshiaki Hanafusa; Masakazu Haneda; Kohjiro Ueki
Journal:  J Diabetes Investig       Date:  2010-10-19       Impact factor: 4.232

10.  Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria.

Authors:  Andrzej S Krolewski; Monika A Niewczas; Jan Skupien; Tomhito Gohda; Adam Smiles; Jon H Eckfeldt; Alessandro Doria; James H Warram
Journal:  Diabetes Care       Date:  2013-08-12       Impact factor: 19.112

View more
  8 in total

1.  Plasma activity of the antioxidant enzymes in predicting diabetic nephropathy progression.

Authors:  Marijana Kovačević; Snežana Mališ; Dragana Pavlović; Maksim Kovačević; Ana Savić Radojević; Ljubica Djukanović
Journal:  Int Urol Nephrol       Date:  2021-10-16       Impact factor: 2.370

2.  Initial Acute Decline in Estimated Glomerular Filtration Rate After Sodium-Glucose Cotransporter-2 Inhibitor in Patients With Chronic Kidney Disease.

Authors:  Seigo Sugiyama; Akira Yoshida; Kunio Hieshima; Noboru Kurinami; Katsunori Jinnouchi; Motoko Tanaka; Tomoko Suzuki; Fumio Miyamoto; Keizo Kajiwara; Tomio Jinnouchi; Hideaki Jinnouchi
Journal:  J Clin Med Res       Date:  2020-11-03

3.  Progression of albuminuria in patients with sickle cell anemia: a multicenter, longitudinal study.

Authors:  Omar Niss; Adam Lane; Monika R Asnani; Marianne E Yee; Ashok Raj; Susan Creary; Courtney Fitzhugh; Prasad Bodas; Santosh L Saraf; Sharada Sarnaik; Prasad Devarajan; Punam Malik
Journal:  Blood Adv       Date:  2020-04-14

4.  Renoprotective Effects of Additional SGLT2 inhibitor Therapy in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease Stages 3b-4: A Real World Report From A Japanese Specialized Diabetes Care Center.

Authors:  Seigo Sugiyama; Hideaki Jinnouchi; Akira Yoshida; Kunio Hieshima; Noboru Kurinami; Katsunori Jinnouchi; Motoko Tanaka; Tomoko Suzuki; Fumio Miyamoto; Keizo Kajiwara; Tomio Jinnouchi
Journal:  J Clin Med Res       Date:  2019-03-18

5.  Drugs Dosing in Geriatric Patients Depending on Kidney Function Estimated by MDRD and Cockroft-Gault Formulas.

Authors:  Małgorzata Szymala-Pędzik; Joanna Żórawska; Jacek Ciach
Journal:  Clin Interv Aging       Date:  2021-12-10       Impact factor: 4.458

6.  Analysis of eGFR index category and annual eGFR slope association with adverse clinical outcomes using real-world Japanese data: a retrospective database study.

Authors:  Ling Zhang; Sibylle Hauske; Yasuhisa Ono; Moe H Kyaw; Dominik Steubl; Yusuke Naito; Keizo Kanasaki
Journal:  BMJ Open       Date:  2022-02-23       Impact factor: 2.692

7.  One-year estimated glomerular filtration rate decline as a risk factor of cardiovascular and renal end-points in high-risk Japanese patients.

Authors:  Shu Meguro; Jun Inaishi; Yasunori Sato; Issei Komuro; Hiroshi Itoh
Journal:  J Diabetes Investig       Date:  2020-12-30       Impact factor: 4.232

Review 8.  SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes.

Authors:  David C Wheeler; June James; Dipesh Patel; Adie Viljoen; Amar Ali; Marc Evans; Kevin Fernando; Debbie Hicks; Nicola Milne; Philip Newland-Jones; John Wilding
Journal:  Diabetes Ther       Date:  2020-09-29       Impact factor: 2.945

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.